Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$26,015
+$3,256 QoQ
Shares Held
166
+11.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,479
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Towne Trust Company, N.A holds $24,022,988 across 11 Drug Manufacturers - General names. NVS ranks #10 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
44,360 | $11,266,108 | |
| 2 | AMGN |
Amgen Inc
|
19,650 | $7,115,658 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,771 | $3,183,073 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
16,251 | $936,382 | |
| 5 | PFE |
Pfizer Inc
|
32,276 | $777,206 | |
| 6 | ABBV |
AbbVie Inc.
|
1,193 | $300,206 | |
| 7 | LLY |
ELI LILLY & Co
|
224 | $268,672 | |
| 8 | AZN |
Astrazeneca PLC
|
612 | $116,047 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,015 | 166 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $22,759 | 149 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $20,542 | 149 | Shares | Sole | 2026-01-26 | |
| No filing history on record for this holder in this stock. | ||||||